Happify Health – Ensemble – Prescription Digital Therapy

One in five people suffer from some form of depression or anxiety, which has been exacerbated by the pandemic. Barriers and limited access to care, coupled with a shortage of mental health physicians has helped spur tremendous growth (and record investments) in digital therapeutics, which is not only filling the gap, but increasingly proving to be a viable option. Chris Wasden, Head of Digital Therapeutics at Happify Health discusses ​these trends and the launch of ​Ensemble, a first-of-its kind prescription digital therapy solution that leverages a myriad of targeted AI, gamification and 100+ Cognitive-Behavioral Therapy (CBT) and mindfulness interventions that was brought to market under the FDA’s Covid Emergency Authorization.​ 

As Head of HappifyDTx and Board Member of the Digital Therapeutic Alliance (DTA), Chris is leading the effort to bring Happify’s platform to the pharmaceutical and healthcare industry. Recently he was a professor at the University of Utah and served as Executive Director of the Sorenson Center for Discovery & Innovation, a digital health game incubator. He is the co-author of two books on innovation, creativity, and leadership: Tension – The Energy of Innovation; and Solving for Why – Change Your Identity, Change Your Future. He is the named inventor on 12 issued patents, has been a founding leader in 10 startups, and has held leadership positions at JP Morgan and PwC. He holds a doctorate from George Washington University in Human and Organizational Learning, and an M.B.A. from UCLA Anderson School.